menu
    • menu

    Company profile for Shanghai Junshi Biosciences

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Junshi BioPharma is an innovation-driven biopharmaceutical company which is dedicated to the discovery and development of innovative drugs and their clinical research and commercialization on a global scale. Our mission is to provide patients with treatment options that work better and cost less. Based on the core platform technology of protein engineering, Junshi stands at the frontier of R&D of macromolecular drugs. With dis...
    Junshi BioPharma is an innovation-driven biopharmaceutical company which is dedicated to the discovery and development of innovative drugs and their clinical research and commercialization on a global scale. Our mission is to provide patients with treatment options that work better and cost less. Based on the core platform technology of protein engineering, Junshi stands at the frontier of R&D of macromolecular drugs. With distinguished capability of innovative drug discovery, advanced biotechnological R&D, large-scale production capacity on the full industry chain and rapidly expanding drug candidate portfolio of tremendous market potential

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Shanghai Junshi BiosciencesChina Flag
    Country
    Country
    China
    Address
    Address
    No.780 Cailun Road, Suite 610, Zhangjiang High-Tec Park,Pudong District, Shang...
    Telephone
    Telephone
    (86)21-50796193
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://junshipharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Junshi Accepts NDA For Roconkibart (IL-17A) for Plaque Psoriasis
    Junshi Accepts NDA For Roconkibart (IL-17A) for Plaque Psoriasis

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200830/0/en/Junshi-Biosciences-Announces-Acceptance-of-the-NDA-for-Roconkibart-IL-17A-for-the-Treatment-of-Moderate-to-Severe-Plaque-Psoriasis.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share
    Junshi Biosciences Meets Primary Endpoints In JS001SC Phase 3
    Junshi Biosciences Meets Primary Endpoints In JS001SC Phase 3

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3193998/0/en/Junshi-Biosciences-Announces-Primary-Endpoints-Met-in-JS001sc-s-Phase-3-Study-for-the-1ST-line-Treatment-of-NSQ-NSCLC.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Junshi Gets FDA IND Nod for Ph2/3 NSCLC Study of JS207
    Junshi Gets FDA IND Nod for Ph2/3 NSCLC Study of JS207

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/17/3168415/0/en/Junshi-Biosciences-Announces-FDA-s-Approval-of-IND-Application-for-Phase-2-3-Clinical-Study-of-JS207-for-the-Neoadjuvant-Treatment-of-NSCLC-Patients.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    Junshi' Phase 3 JS005 Meets Primary Endpoints in Plaque Psoriasis
    Junshi' Phase 3 JS005 Meets Primary Endpoints in Plaque Psoriasis

    07 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/07/3145717/0/en/Junshi-Biosciences-Announces-the-Phase-3-Study-of-JS005-IL-17A-for-the-Treatment-of-Moderate-to-Severe-Plaque-Psoriasis-Met-Primary-Endpoints.html

    GLOBENEWSWIRE
    07 Sep 2025
    Share Share
    TREOS, Charité, Junshi Launch Ph2 Trial in MSS Colorectal Cancer
    TREOS, Charité, Junshi Launch Ph2 Trial in MSS Colorectal Cancer

    27 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/27/3139866/0/en/TREOS-Bio-Partners-with-Charit%C3%A9-Berlin-and-Junshi-Biosciences-to-Launch-Pivotal-Phase-II-Clinical-Trial-in-Refractory-MSS-Colorectal-Cancer.html

    GLOBENEWSWIRE
    27 Aug 2025
    Share Share
    Junshi Bio' sNDA for Toripalimab Accepted as Urothelial Carcinoma
    Junshi Bio' sNDA for Toripalimab Accepted as Urothelial Carcinoma

    08 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/08/3130114/0/en/Junshi-Biosciences-Announces-the-Acceptance-of-the-sNDA-for-Toripalimab-as-the-1st-line-Treatment-of-HER2-expressing-Urothelial-Carcinoma.html

    GLOBENEWSWIRE
    08 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search